Tou-Tong-Ting decoction therapy for Migraine with Liver Yang Hyperactive syndrome: a single-blinded, randomized controlled trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Control group:Flunarizine Hydrochloride Capsule;Test group:Tou‐Tong‐Ting decoction; CONDITION: Migraine PRIMARY OUTCOME: Migraine severity score;TCM syndrome integral of migraine; SECONDARY OUTCOME: MIDAS score;VAS score;HIT‐6 score;MSQ score;PSQI score;SAS score;SDS score; INCLUSION CRITERIA: 1. Conform to the diagnostic criteria of migraine (including migraine with aura and migraine with aura); 2. Conform to the diagnostic criteria of migraine in TCM of Liver Yang Hyperactive syndrome; 3. Age 18‐65; 4. Migraine attacks at least once a month in recent three months; 5. Volunteer to participate in this study and sign the informed consent.
Epistemonikos ID: e210f20e79d1964d6ad8f29bf8f81321659b669b
First added on: Feb 20, 2024